Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Privia Health Group, Inc. or DaVita Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Privia Health Group, Inc. and DaVita Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Privia Health Group, Inc. and DaVita Inc.

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Latest Health Care Providers & Services and Privia Health Group, Inc., DaVita Inc. Stock News

As of September 2, 2026, Privia Health Group, Inc. had a $2.6 billion market capitalization, compared to the Health Care Providers & Services median of $1.7 million. Privia Health Group, Inc.’s stock is down 12.8% in 2026, down 0.9% in the previous five trading days and down 10.57% in the past year.

Currently, Privia Health Group, Inc.’s price-earnings ratio is 94.7. Privia Health Group, Inc.’s trailing 12-month revenue is $2.4 billion with a 1.2% net profit margin. Year-over-year quarterly sales growth most recently was 21.4%. Analysts expect adjusted earnings to reach $0.876 per share for the current fiscal year. Privia Health Group, Inc. does not currently pay a dividend.

As of September 2, 2026, DaVita Inc. had a $11.4 billion market cap, putting it in the 79th percentile of all stocks. DaVita Inc.’s stock is up 59.9% in 2026, up 1.6% in the previous five trading days and up 30.99% in the past year.

Currently, DaVita Inc.’s price-earnings ratio is 15.3. DaVita Inc.’s trailing 12-month revenue is $14.0 billion with a 6.0% net profit margin. Year-over-year quarterly sales growth most recently was 5.2%. Analysts expect adjusted earnings to reach $14.845 per share for the current fiscal year. DaVita Inc. does not currently pay a dividend.

How We Compare Privia Health Group, Inc. and DaVita Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Privia Health Group, Inc. and DaVita Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Privia Health Group, Inc. and DaVita Inc. Stock Value Grades

Company	Ticker	Value
Privia Health Group, Inc.	PRVA	D
DaVita Inc.	DVA	A

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Privia Health Group, Inc. has a Value Score of 21, which is Expensive. DaVita Inc. has a Value Score of 93, which is Deep Value.

The Value Stock Winner: DaVita Inc.

As you can clearly see from the Value Grade breakdown above, DaVita Inc. is considered to have better value than Privia Health Group, Inc.. For investors who focus solely on a company’s valuation, DaVita Inc. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Privia Health Group, Inc. and DaVita Inc. Growth Grades

Company	Ticker	Growth
Privia Health Group, Inc.	PRVA	B
DaVita Inc.	DVA	B

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Privia Health Group, Inc. has a Growth Score of 69, which is Strong. DaVita Inc. has a Growth Score of 73, which is Strong.

The Growth Grade Winner: It’s a Tie!

Looking at the Growth Grade breakdown above, both Privia Health Group, Inc. and DaVita Inc. have a grade of B. For investors who focus solely on a company’s upward growth, further research should be conducted into both companies’ other financial metrics before deciding whether to invest.

Privia Health Group, Inc. and DaVita Inc.’s Momentum Grades

Company	Ticker	Momentum
Privia Health Group, Inc.	PRVA	D
DaVita Inc.	DVA	C

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Privia Health Group, Inc. has a Momentum Score of 31, which is Weak. DaVita Inc. has a Momentum Score of 58, which is Average.

The Momentum Stock Winner: No Clear Winner

Neither Privia Health Group, Inc. or DaVita Inc. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Privia Health Group, Inc. or DaVita Inc. is the better investment when it comes to momentum.

Other Privia Health Group, Inc. and DaVita Inc. Grades

In addition to Growth, Momentum and Value, A+ Investor also provides grades for Estimate Revisions and Quality.

Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Privia Health Group, Inc. and DaVita Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Privia Health Group, Inc. or DaVita Inc. Stock?

Overall, Privia Health Group, Inc. stock has a Value Score of 21, Growth Score of 69 and Momentum Score of 31.

DaVita Inc. stock has a Value Score of 93, Growth Score of 73 and Momentum Score of 58.

Comparing Privia Health Group, Inc. and DaVita Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.